title: Improvement in esophageal motor abnormalities in systemic sclerosis patients treated with cyclosporine: comment on the article by Clements et al.
authors.forename: P
authors.initials: P
authors.lastname: Zentilin
authors.forename: V
authors.initials: V
authors.lastname: Savarino
authors.forename: F
authors.initials: F
authors.lastname: Puppo
authors.forename: M
authors.initials: M
authors.lastname: Scudeletti
authors.forename: F
authors.initials: F
authors.lastname: Indiveri
mesh_terms: D000328:Adult; D016572:Cyclosporine / Q000627:therapeutic use*; D015154:Esophageal Motility Disorders / Q000188:drug therapy* / Q000209:etiology*; D005260:Female; D006801:Humans; D012595:Scleroderma, Systemic / Q000150:complications*
chemical_list: D016572:Cyclosporine